Beta-catenin independent WNT signaling (Homo sapiens)

From WikiPathways

Revision as of 18:50, 18 July 2016 by Mkutmon (Talk | contribs)
Jump to: navigation, search
20, 23, 53, 72, 105...56, 584, 1728, 8511028, 41, 1102, 70, 73, 92, 11722755612, 24, 31, 7722, 3220, 69, 73, 78, 106...5628, 50, 102, 1075, 13, 615029, 391184, 17, 38, 602546, 51, 81, 82, 95...5, 10, 26, 34, 47...62, 64, 97, 1095, 10, 11, 13, 27...33, 62, 9546, 51, 81, 8222752, 18, 36, 48, 62...10228, 45, 87, 93, 10239, 65, 1019, 567, 63, 100, 103, 112...25, 30, 37, 80, 11433, 62, 953, 6, 25, 53, 68...15, 19, 43, 67, 10621, 72, 10222, 3210956, 11152, 88, 9618, 48, 62, 9511022, 32, 7914, 34, 35, 44, 49...8, 8616, 89clathrin-coated endocytic vesiclecytosolendoplasmic reticulum lumennucleoplasmGNG12 PSMD12 N4GlycoAsn-PalmS WNT11 GNG7 MOV10 p-S257-NFATC1 Mg2+ PSMD9 p-DVL2 GNG12 EIF2C4 NLK mRNA FZD3 EIF2C2 N4GlycoAsn-PalmS WNT4 N4GlycoAsn-PalmS WNT5A(36-380) CLTC AP2A2(1-939) EIF2C2 LEF1 PRKG2 FZD3 N4GlycoAsn-PalmS WNT11 p-T286 CAMK2:CaMPSME2 clathrin:AP-2AP2M1 FZD2 DVL2 H2OPLCB1 PRKG1 FZD1 Zn2+ AXIN2 mRNA WNT5A:FZD4:p-DVL2:AP-2:clathrinRAC1 unknown kinaseGNG2 N4GlycoAsn-PalmS WNT5A(36-380) GNG2 AP2S1 p-T286,305,306-CAMK2:MAP3K7N4GlycoAsn-PalmS WNT5B GNB3 GNAO1 PSME4 UBC(77-152) AP2S1 p-DVL2 WNT5A/11:FZD:G-protein (alpha o/t2) activeGNG2 ITPR1 FZD2 CLTB PDE6A FZD4 AP2A2(1-939) Phosphatidylserinepp-DVL3 UbiquitinGNG3 miR-92b N4GlycoAsn-PalmS WNT5A(36-380) UBC(153-228) VANGL2 AP2A2(1-939) FZD6 GTP ADPp-T286,T305,T306-CAMK2A ROR2 DAAM1p-DVLPSMD1 FZD1 GNG7 Fe3+ GNG12 DAG TNRC6C GNG2 GNGT2 G-protein beta-gammacomplexVANGL2 GMPGNB4 NLKMAP3K7pT497,T638,S657-PRKCAN4GlycoAsn-PalmS WNT5A(36-380) activated PKC alphaN4GlycoAsn-PalmS WNT4 FZD2 TCF dependentsignaling inresponse to WNTN4GlycoAsn-PalmS WNT1 GNAT2:PDE6PSMB1 FZD4 UBC(533-608) CALM1 N4GlycoAsn-PalmS WNT11 pp-DVLCAMK2APARD6A:pp-DVL2:SMURFUBC(609-684) CTNNB1 GNG5 RPS27A(1-76) p-T187-MAP3K7FZD6 GNG8 PSMD3 AP2A1 PRKG dimerN4GlycoAsn-PalmS WNT5A(36-380) AP2M1 CAMK2A PPP3CA PLCB3 GTP SMURF1 FZD4 PDE6B FZD5 p-T298-NLK UBB(1-76) N4GlycoAsn-PalmS WNT5A(36-380) WNT5A:FZD4:p-DVL2:ARRB2:AP-2:clathrinGNB1 FZD8 PSMB2 SMURF2 VANGL2:SCRIBDAAM1 PDE6G pp-DVL3 GNB1 GNG5 FZD4 GNB5 FZD6 PSMC6 PFN1PPP3CB CAMK2A PSMD14 PARD6A FZD7 pp-DVL2 WNT5A:FZDs/RORpT298-NLK dimerGNGT2 WNT5A/11:FZDGNAT2 GNG8 ROR2 p-DVL2 FZD3 PSMD13 ATPN4GlycoAsn-PalmS WNT11 PPP3CA TNRC6B GNG4 PSMB10 GNG7 pp-DVL3 UBA52(1-76) unknown kinaseN4GlycoAsn-PalmS WNT1 GTP FZD5 TCF/LEF:CTNNB1FZD8 ppDVL:DAAM1:RHOA:GTPFZD4 p-DVL3 GNG8 VANGL2PRKCA GNB5 PSMB6 NFATC1:CaN:CaMGDP DAGADPGNB4 MOV10 PSMA1 CALM1 RAC3 p-S257-NFATC1 NFATC1:CaN:CaMPSMD5 GNG7 GNAO1 WNT5A:FZDs/RORPFN1 GTP FZD4 CALM1 pT201,T212-TCF7L2 PLCB3 WNT5A/11:FZD:G-protein (alpha o/t2) inactivepT155,S166-LEF1 GNB1 FZD3 LEF1 GNAT2 FZD2 p-T286,T305,T306-CAMK2AAP2M1 p-T286-CAMK2A 26S proteasomepp-DVL1 FZD3 N4GlycoAsn-PalmS-WNT5A:RYK:VANGL2pT298-NLK dimerCALM1 'canonical' WNTtarget genesH2OAP2A1 IP3 receptorhomotetramerGNG3 GNB2 ROR1 PARD6A PSMA2 FZD5 PSME1 pp-DVL3 GTP pp-DVL1 FZD5 ATPGNGT2 GNAT2 CTNNB1 EIF2C4 SMURF2 PARD6A:pp-DVL2FZD6 ATPGNG13 pp-DVL3 GNG3 CLTA Ca2+ ATPCa2+ ITPR3 PSMD2 EIF2C3 PSMA8 Ca2+WNT:FZDUBC(305-380) PSMA3 RAC2 Ca2+ AP2S1 ADPp-TCF/LEF:CTNNB1p-DVL3 N4GlycoAsn-PalmS WNT5A(36-380) PSMB11 GNG10 CTNNB1 NLK mRNAPSMB5 CALM1 UBC(1-76) DAG Fe3+ GNG7 RHOA GNG4 p-DVL2 ADPFZD1 Fe3+ PSMB9 PSMC2 N4GlycoAsn-PalmS WNT5A(36-380) GNG4 pp-DVL2 PRKG homodimer:cGMPPPP3R1 TCF7L2 FZD2 miR-92b RISCunknown kinaseADPPLCB2 CALM1 PLCB2 NLK mRNA:miR-92bRISCppDVL:DAAM1ROR2 GNB5 FZD5 CLTC ATPFZD5 unknown kinasePRKCB PRKG1 PPP3CB ADPUBC(457-532) ub-PRICKLE1FZD2/FZD5/ROR2GNG11 GNB4 FZD4 PSMC5 GNG5 FZD3 PSMA4 GNB2 PARD6A:p-DVL2GNG13 PSMB3 ROR1 PDE6B FZD6 RHOA:GTP:Mg2+N4GlycoAsn-PalmS WNT1 pS5,S82,S84-VANGL2 DAAM1 G-protein alpha(o/t2)FZD3 DVL2ATPGNGT2 CLTA Ca2+ TNRC6A GNB3 AP2A1 GNG13 GNB2 PSMA5 N4GlycoAsn-PalmS-WNT5A:FZD4ADPGNAT2 WNT/Ca2+ FZDsFZD4 GNAT2 TCF7L1 PPP3CA GNG10 GTPGDPFZD2 N4GlycoAsn-PalmS WNT11 ITPR3 Ca2+ GNB2 GNG4 GNGT1 WNT5A:FZDFZD2 N4GlycoAsn-PalmS WNT5A(36-380) GNG11 FZD6 FZD7 N4GlycoAsn-PalmS WNT5A(36-380) DAAM1 FZD5 pT497,T638,S657-PRKCA PSMD6 PSMB8 FZD1 PSMB4 ITPR1 G-proteinbeta-gamma:PLC beta1/2/3FZD4PSMC3 Calcineurin:Calmodulin (CaN:CaM)miR-92b pp-DVL2 RYKATPppDVL:DAAM1:PFN1PSMD8 TNRC6A PSMC1 AP2B1 ppDVL:RAC:GTPCalcineurin (CaN)pp-DVL2 AP2B1 PSMD4 GTP PSMC4 FZD4 FZD4 N4GlycoAsn-PalmS WNT5A(36-380) GNB1 N4GlycoAsn-PalmS WNT4 UBC(229-304) ROR2 PPP3CB PPP3CB PLCB1 ROR2 PLC-beta 1/2/3GTP pp-DVL1 p-DVL2 FZD2 pp-DVL2 GNG13 ARRB2FZD3 GNG12 SMURF1 CALM1:4xCa2+GNB1 Ca2+ Activated Proteinkinase C (alpha,beta, gammaisoforms)RAC1 VANGL2 ROR1 FZD5 FZD3PDE6TCF7L2 GNB5 cGMPPDE6G SCRIBGNG11 GNG12 GNG5 GNB3 pp-DVL2 PPP3R1 N4GlycoAsn-PalmS WNT5B Phosphatidylserine RAC2 FZD3 ITPR:I(1,4,5)P3tetramerFe3+ FZD5 FZD1 TNRC6B FZD4 p-12S-NFATC1N4GlycoAsn-PalmS WNT5A(36-380) N4GlycoAsn-PalmS WNT5A(36-380) PCP pathway FZDsN4GlycoAsn-PalmS WNT5A(36-380) pp-DVL1 N4GlycoAsn-PalmS WNT11 pp-DVL2 p-S-DVL1 ADPGNAT2:GTPFZD7 GNG2 Ca2+ N4GlycoAsn-PalmS WNT5A(36-380) GNG11 GNGT1 Mg2+ GNB5 UBC(381-456) TCF7 PPP3R1 Ca2+I(1,4,5)P3PSMD7 GNG4 GNGT2 WNT5A:FZD4:DVL2p-DVL2 EIF2C1 RHOA PRKG2 PRKCG CLTB GNGT1 GNB4 SCRIB UBB(77-152) GNG8 GNB4 GNG8 p-T298-NLK GNG10 CLTA PPP3R1 GNAO1 GDP N4GlycoAsn-PalmS WNT5A(36-380) I(1,4,5)P3 CLTB FZD3 CAMK2:CaMGNGT1 GNAO1 ATPADPROR2PRICKLE1'canonical' WNTtarget genetranscriptsZn2+ VANGL2:SCRIB:FZD3GNG11 PCP pathway WNTsGNG13 FZD2 UBB(153-228) GNB2 PI(4,5)P2ITPR2 WNT5A:FZD4:p-DVL2GNB3 p-S-DVL1 N4GlycoAsn-PalmS WNT5B PARD6A EIF2C1 ARRB2 PPP3CA N4GlycoAsn-PalmSWNT5A:ROR2:p-VANGL2GNG3 SMURFZn2+ ATPpp-DVL1 PSME3 cGMP GNGT1 ITPR2 p-T286,T305,T306-CAMK2A PSMA6 WNT:FZD:pDVLPSMD10 N4GlycoAsn-PalmS WNT5A(36-380) GNB3 PSMF1 FZD7 GNG10 PSMA7 TNRC6C N4GlycoAsn-PalmSWNT5A(36-380)AXIN2 gene PSMD11 PiSCRIB N4GlycoAsn-PalmS WNT11 MAP3K7 WNT5A-binding FZDsRAC:GTPCa2+ VANGL2 Zn2+ RAC3 FZD6 HeterotrimericG-protein (o/t2)(inactive)GNG5 AP2B1 Phosphatidylserine FZD7 GNG3 GNG10 N4GlycoAsn-PalmSWNT5A:ROR2:VANGL2PSMB7 WNT5A/WNT11RYK GNAT2 CLTC EIF2C3 N4GlycoAsn-PalmS WNT5A(36-380) PDE6A 83, 91183, 9154, 72, 9040


Description

Humans and mice have 19 identified WNT proteins that were originally classified as either 'canonical' or 'non-canonical' depending upon whether they were able to transform the mouse mammary epithelial cell line C57MG and to induce secondary axis formation in Xenopus (Wong et al, 1994; Du et al, 1995). So-called canonical WNTs, including Wnt1, 3, 3a and 7, initiate signaling pathways that destabilize the destruction complex and allow beta-catenin to accumulate and translocate to the nucleus where it promotes transcription (reviewed in Saito-Diaz et al, 2013). Non-canonical WNTs, including Wnt 2, 4, 5a, 5b, 6, 7b, and Wnt11 activate beta-catenin-independent responses that regulate many aspects of morphogenesis and development, often by impinging on the cytoskeleton (reviewed in van Amerongen, 2012). Two of the main beta-catenin-independent pathways are the Planar Cell Polarity (PCP) pathway, which controls the establishment of polarity in the plane of a field of cells, and the WNT/Ca2+ pathway, which promotes the release of intracellular calcium and regulates numerous downstream effectors (reviewed in Gao, 2012; De, 2011). View original pathway at:Reactome.

Comments

Reactome Converter 
Pathway is converted from Reactome id:

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Rothbächer U, Laurent MN, Deardorff MA, Klein PS, Cho KW, Fraser SE.; ''Dishevelled phosphorylation, subcellular localization and multimerization regulate its role in early embryogenesis.''; PubMed Europe PMC Scholia
  2. Malbon CC, Wang H, Moon RT.; ''Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance?''; PubMed Europe PMC Scholia
  3. Smrcka AV.; ''G protein βγ subunits: central mediators of G protein-coupled receptor signaling.''; PubMed Europe PMC Scholia
  4. Keeble TR, Cooper HM.; ''Ryk: a novel Wnt receptor regulating axon pathfinding.''; PubMed Europe PMC Scholia
  5. Shen X, Li H, Ou Y, Tao W, Dong A, Kong J, Ji C, Yu S.; ''The secondary structure of calcineurin regulatory region and conformational change induced by calcium/calmodulin binding.''; PubMed Europe PMC Scholia
  6. Mancini M, Toker A.; ''NFAT proteins: emerging roles in cancer progression.''; PubMed Europe PMC Scholia
  7. Macheda ML, Sun WW, Kugathasan K, Hogan BM, Bower NI, Halford MM, Zhang YF, Jacques BE, Lieschke GJ, Dabdoub A, Stacker SA.; ''The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling.''; PubMed Europe PMC Scholia
  8. Brantjes H, Roose J, van De Wetering M, Clevers H.; ''All Tcf HMG box transcription factors interact with Groucho-related co-repressors.''; PubMed Europe PMC Scholia
  9. Du SJ, Purcell SM, Christian JL, McGrew LL, Moon RT.; ''Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos.''; PubMed Europe PMC Scholia
  10. Slusarski DC, Yang-Snyder J, Busa WB, Moon RT.; ''Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A.''; PubMed Europe PMC Scholia
  11. Wensel TG.; ''Signal transducing membrane complexes of photoreceptor outer segments.''; PubMed Europe PMC Scholia
  12. Yu H, Smallwood PM, Wang Y, Vidaltamayo R, Reed R, Nathans J.; ''Frizzled 1 and frizzled 2 genes function in palate, ventricular septum and neural tube closure: general implications for tissue fusion processes.''; PubMed Europe PMC Scholia
  13. Ishitani T, Ninomiya-Tsuji J, Matsumoto K.; ''Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.''; PubMed Europe PMC Scholia
  14. Qian D, Jones C, Rzadzinska A, Mark S, Zhang X, Steel KP, Dai X, Chen P.; ''Wnt5a functions in planar cell polarity regulation in mice.''; PubMed Europe PMC Scholia
  15. Gao C, Chen YG.; ''Dishevelled: The hub of Wnt signaling.''; PubMed Europe PMC Scholia
  16. Slusarski DC, Corces VG, Moon RT.; ''Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling.''; PubMed Europe PMC Scholia
  17. Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW.; ''Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.''; PubMed Europe PMC Scholia
  18. Angers S, Moon RT.; ''Proximal events in Wnt signal transduction.''; PubMed Europe PMC Scholia
  19. Lee RH, Iioka H, Ohashi M, Iemura S, Natsume T, Kinoshita N.; ''XRab40 and XCullin5 form a ubiquitin ligase complex essential for the noncanonical Wnt pathway.''; PubMed Europe PMC Scholia
  20. Chen TY, Illing M, Molday LL, Hsu YT, Yau KW, Molday RS.; ''Subunit 2 (or beta) of retinal rod cGMP-gated cation channel is a component of the 240-kDa channel-associated protein and mediates Ca(2+)-calmodulin modulation.''; PubMed Europe PMC Scholia
  21. Liu W, Sato A, Khadka D, Bharti R, Diaz H, Runnels LW, Habas R.; ''Mechanism of activation of the Formin protein Daam1.''; PubMed Europe PMC Scholia
  22. Narimatsu M, Bose R, Pye M, Zhang L, Miller B, Ching P, Sakuma R, Luga V, Roncari L, Attisano L, Wrana JL.; ''Regulation of planar cell polarity by Smurf ubiquitin ligases.''; PubMed Europe PMC Scholia
  23. Rusnak F, Mertz P.; ''Calcineurin: form and function.''; PubMed Europe PMC Scholia
  24. Wong GT, Gavin BJ, McMahon AP.; ''Differential transformation of mammary epithelial cells by Wnt genes.''; PubMed Europe PMC Scholia
  25. Yu A, Xing Y, Harrison SC, Kirchhausen T.; ''Structural analysis of the interaction between Dishevelled2 and clathrin AP-2 adaptor, a critical step in noncanonical Wnt signaling.''; PubMed Europe PMC Scholia
  26. Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G, Markman M, Lamers W, Destree O, Clevers H.; ''Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse.''; PubMed Europe PMC Scholia
  27. Witzel S, Zimyanin V, Carreira-Barbosa F, Tada M, Heisenberg CP.; ''Wnt11 controls cell contact persistence by local accumulation of Frizzled 7 at the plasma membrane.''; PubMed Europe PMC Scholia
  28. Stratton MM, Chao LH, Schulman H, Kuriyan J.; ''Structural studies on the regulation of Ca2+/calmodulin dependent protein kinase II.''; PubMed Europe PMC Scholia
  29. Meneghini MD, Ishitani T, Carter JC, Hisamoto N, Ninomiya-Tsuji J, Thorpe CJ, Hamill DR, Matsumoto K, Bowerman B.; ''MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans.''; PubMed Europe PMC Scholia
  30. González-Sancho JM, Brennan KR, Castelo-Soccio LA, Brown AM.; ''Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize beta-catenin.''; PubMed Europe PMC Scholia
  31. González-Sancho JM, Greer YE, Abrahams CL, Takigawa Y, Baljinnyam B, Lee KH, Lee KS, Rubin JS, Brown AM.; ''Functional consequences of Wnt-induced dishevelled 2 phosphorylation in canonical and noncanonical Wnt signaling.''; PubMed Europe PMC Scholia
  32. O'Connell MP, Fiori JL, Baugher KM, Indig FE, French AD, Camilli TC, Frank BP, Earley R, Hoek KS, Hasskamp JH, Elias EG, Taub DD, Bernier M, Weeraratna AT.; ''Wnt5A activates the calpain-mediated cleavage of filamin A.''; PubMed Europe PMC Scholia
  33. Goode BL, Eck MJ.; ''Mechanism and function of formins in the control of actin assembly.''; PubMed Europe PMC Scholia
  34. Niehrs C.; ''The complex world of WNT receptor signalling.''; PubMed Europe PMC Scholia
  35. Ahumada A, Slusarski DC, Liu X, Moon RT, Malbon CC, Wang HY.; ''Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP.''; PubMed Europe PMC Scholia
  36. van Amerongen R.; ''Alternative Wnt pathways and receptors.''; PubMed Europe PMC Scholia
  37. Keeble TR, Halford MM, Seaman C, Kee N, Macheda M, Anderson RB, Stacker SA, Cooper HM.; ''The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum.''; PubMed Europe PMC Scholia
  38. Graham TA, Weaver C, Mao F, Kimelman D, Xu W.; ''Crystal structure of a beta-catenin/Tcf complex.''; PubMed Europe PMC Scholia
  39. Kühl M, Sheldahl LC, Malbon CC, Moon RT.; ''Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus.''; PubMed Europe PMC Scholia
  40. Tanegashima K, Zhao H, Dawid IB.; ''WGEF activates Rho in the Wnt-PCP pathway and controls convergent extension in Xenopus gastrulation.''; PubMed Europe PMC Scholia
  41. Khadka DK, Liu W, Habas R.; ''Non-redundant roles for Profilin2 and Profilin1 during vertebrate gastrulation.''; PubMed Europe PMC Scholia
  42. Montcouquiol M, Sans N, Huss D, Kach J, Dickman JD, Forge A, Rachel RA, Copeland NG, Jenkins NA, Bogani D, Murdoch J, Warchol ME, Wenthold RJ, Kelley MW.; ''Asymmetric localization of Vangl2 and Fz3 indicate novel mechanisms for planar cell polarity in mammals.''; PubMed Europe PMC Scholia
  43. Axelrod JD.; ''Unipolar membrane association of Dishevelled mediates Frizzled planar cell polarity signaling.''; PubMed Europe PMC Scholia
  44. Penzo-Mendèz A, Umbhauer M, Djiane A, Boucaut JC, Riou JF.; ''Activation of Gbetagamma signaling downstream of Wnt-11/Xfz7 regulates Cdc42 activity during Xenopus gastrulation.''; PubMed Europe PMC Scholia
  45. Liu X, Liu T, Slusarski DC, Yang-Snyder J, Malbon CC, Moon RT, Wang H.; ''Activation of a frizzled-2/beta-adrenergic receptor chimera promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via Galphao and Galphat.''; PubMed Europe PMC Scholia
  46. Dejmek J, Säfholm A, Kamp Nielsen C, Andersson T, Leandersson K.; ''Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.''; PubMed Europe PMC Scholia
  47. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W.; ''Functional interaction of beta-catenin with the transcription factor LEF-1.''; PubMed Europe PMC Scholia
  48. Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P, Song Z, Qian C, Chen Y, Yang S, Wang Y.; ''miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.''; PubMed Europe PMC Scholia
  49. Sagot I, Rodal AA, Moseley J, Goode BL, Pellman D.; ''An actin nucleation mechanism mediated by Bni1 and profilin.''; PubMed Europe PMC Scholia
  50. Sheldahl LC, Park M, Malbon CC, Moon RT.; ''Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner.''; PubMed Europe PMC Scholia
  51. Ma L, Wang HY.; ''Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway.''; PubMed Europe PMC Scholia
  52. Habas R, Kato Y, He X.; ''Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1.''; PubMed Europe PMC Scholia
  53. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe GC, Mundlos S, Shibuya H, Takada S, Minami Y.; ''The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway.''; PubMed Europe PMC Scholia
  54. Chen W, ten Berge D, Brown J, Ahn S, Hu LA, Miller WE, Caron MG, Barak LS, Nusse R, Lefkowitz RJ.; ''Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4.''; PubMed Europe PMC Scholia
  55. Bonacci TM, Ghosh M, Malik S, Smrcka AV.; ''Regulatory interactions between the amino terminus of G-protein betagamma subunits and the catalytic domain of phospholipase Cbeta2.''; PubMed Europe PMC Scholia
  56. Dai L, Aye Thu C, Liu XY, Xi J, Cheung PC.; ''TAK1, more than just innate immunity.''; PubMed Europe PMC Scholia
  57. Montcouquiol M, Rachel RA, Lanford PJ, Copeland NG, Jenkins NA, Kelley MW.; ''Identification of Vangl2 and Scrb1 as planar polarity genes in mammals.''; PubMed Europe PMC Scholia
  58. Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanafusa H, Takada R, Takada S, Nishida E.; ''JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates.''; PubMed Europe PMC Scholia
  59. Schmitt AM, Shi J, Wolf AM, Lu CC, King LA, Zou Y.; ''Wnt-Ryk signalling mediates medial-lateral retinotectal topographic mapping.''; PubMed Europe PMC Scholia
  60. Omer CA, Miller PJ, Diehl RE, Kral AM.; ''Identification of Tcf4 residues involved in high-affinity beta-catenin binding.''; PubMed Europe PMC Scholia
  61. MacDonald BT, Tamai K, He X.; ''Wnt/beta-catenin signaling: components, mechanisms, and diseases.''; PubMed Europe PMC Scholia
  62. Birbach A.; ''Profilin, a multi-modal regulator of neuronal plasticity.''; PubMed Europe PMC Scholia
  63. Wang HY, Malbon CC.; ''Wnt-frizzled signaling to G-protein-coupled effectors.''; PubMed Europe PMC Scholia
  64. Shin TH, Yasuda J, Rocheleau CE, Lin R, Soto M, Bei Y, Davis RJ, Mello CC.; ''MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans.''; PubMed Europe PMC Scholia
  65. Jenny A, Reynolds-Kenneally J, Das G, Burnett M, Mlodzik M.; ''Diego and Prickle regulate Frizzled planar cell polarity signalling by competing for Dishevelled binding.''; PubMed Europe PMC Scholia
  66. Saneyoshi T, Kume S, Amasaki Y, Mikoshiba K.; ''The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos.''; PubMed Europe PMC Scholia
  67. Sato A, Khadka DK, Liu W, Bharti R, Runnels LW, Dawid IB, Habas R.; ''Profilin is an effector for Daam1 in non-canonical Wnt signaling and is required for vertebrate gastrulation.''; PubMed Europe PMC Scholia
  68. Rocheleau CE, Yasuda J, Shin TH, Lin R, Sawa H, Okano H, Priess JR, Davis RJ, Mello CC.; ''WRM-1 activates the LIT-1 protein kinase to transduce anterior/posterior polarity signals in C. elegans.''; PubMed Europe PMC Scholia
  69. Boutros M, Paricio N, Strutt DI, Mlodzik M.; ''Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling.''; PubMed Europe PMC Scholia
  70. Ishitani S, Inaba K, Matsumoto K, Ishitani T.; ''Homodimerization of Nemo-like kinase is essential for activation and nuclear localization.''; PubMed Europe PMC Scholia
  71. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT.; ''The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.''; PubMed Europe PMC Scholia
  72. Sato A, Yamamoto H, Sakane H, Koyama H, Kikuchi A.; ''Wnt5a regulates distinct signalling pathways by binding to Frizzled2.''; PubMed Europe PMC Scholia
  73. Li C, Chen H, Hu L, Xing Y, Sasaki T, Villosis MF, Li J, Nishita M, Minami Y, Minoo P.; ''Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2.''; PubMed Europe PMC Scholia
  74. Mikels AJ, Nusse R.; ''Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.''; PubMed Europe PMC Scholia
  75. Wong HC, Mao J, Nguyen JT, Srinivas S, Zhang W, Liu B, Li L, Wu D, Zheng J.; ''Structural basis of the recognition of the dishevelled DEP domain in the Wnt signaling pathway.''; PubMed Europe PMC Scholia
  76. Lai SL, Chien AJ, Moon RT.; ''Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis.''; PubMed Europe PMC Scholia
  77. Andre P, Wang Q, Wang N, Gao B, Schilit A, Halford MM, Stacker SA, Zhang X, Yang Y.; ''The Wnt coreceptor Ryk regulates Wnt/planar cell polarity by modulating the degradation of the core planar cell polarity component Vangl2.''; PubMed Europe PMC Scholia
  78. Tree DR, Shulman JM, Rousset R, Scott MP, Gubb D, Axelrod JD.; ''Prickle mediates feedback amplification to generate asymmetric planar cell polarity signaling.''; PubMed Europe PMC Scholia
  79. Yu A, Rual JF, Tamai K, Harada Y, Vidal M, He X, Kirchhausen T.; ''Association of Dishevelled with the clathrin AP-2 adaptor is required for Frizzled endocytosis and planar cell polarity signaling.''; PubMed Europe PMC Scholia
  80. Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K.; ''The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling.''; PubMed Europe PMC Scholia
  81. Kurayoshi M, Yamamoto H, Izumi S, Kikuchi A.; ''Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling.''; PubMed Europe PMC Scholia
  82. Habas R, Dawid IB, He X.; ''Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation.''; PubMed Europe PMC Scholia
  83. Rebecchi MJ, Pentyala SN.; ''Structure, function, and control of phosphoinositide-specific phospholipase C.''; PubMed Europe PMC Scholia
  84. Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E.; ''The way Wnt works: components and mechanism.''; PubMed Europe PMC Scholia
  85. Dutil EM, Toker A, Newton AC.; ''Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1).''; PubMed Europe PMC Scholia
  86. Minami Y, Oishi I, Endo M, Nishita M.; ''Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases.''; PubMed Europe PMC Scholia
  87. Keranen LM, Dutil EM, Newton AC.; ''Protein kinase C is regulated in vivo by three functionally distinct phosphorylations.''; PubMed Europe PMC Scholia
  88. Axelrod JD, Miller JR, Shulman JM, Moon RT, Perrimon N.; ''Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and Wingless signaling pathways.''; PubMed Europe PMC Scholia
  89. Malbon CC.; ''Frizzleds: new members of the superfamily of G-protein-coupled receptors.''; PubMed Europe PMC Scholia
  90. Ma L, Wang HY.; ''Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca2+ pathway.''; PubMed Europe PMC Scholia
  91. Lv L, Wan C, Chen B, Li M, Liu Y, Ni T, Yang Y, Liu Y, Cong X, Mao G, Xue Q.; ''Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.''; PubMed Europe PMC Scholia
  92. Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC.; ''Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development.''; PubMed Europe PMC Scholia
  93. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM.; ''Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.''; PubMed Europe PMC Scholia
  94. Banno Y, Yada Y, Nozawa Y.; ''Purification and characterization of membrane-bound phospholipase C specific for phosphoinositides from human platelets.''; PubMed Europe PMC Scholia
  95. Fradkin LG, Dura JM, Noordermeer JN.; ''Ryks: new partners for Wnts in the developing and regenerating nervous system.''; PubMed Europe PMC Scholia
  96. Okamura H, Aramburu J, García-Rodríguez C, Viola JP, Raghavan A, Tahiliani M, Zhang X, Qin J, Hogan PG, Rao A.; ''Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity.''; PubMed Europe PMC Scholia
  97. Watanabe N, Higashida C.; ''Formins: processive cappers of growing actin filaments.''; PubMed Europe PMC Scholia
  98. Hogan PG, Chen L, Nardone J, Rao A.; ''Transcriptional regulation by calcium, calcineurin, and NFAT.''; PubMed Europe PMC Scholia
  99. Poy F, Lepourcelet M, Shivdasani RA, Eck MJ.; ''Structure of a human Tcf4-beta-catenin complex.''; PubMed Europe PMC Scholia
  100. Djiane A, Riou J, Umbhauer M, Boucaut J, Shi D.; ''Role of frizzled 7 in the regulation of convergent extension movements during gastrulation in Xenopus laevis.''; PubMed Europe PMC Scholia
  101. Amano M, Nakayama M, Kaibuchi K.; ''Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.''; PubMed Europe PMC Scholia
  102. Kühl M, Sheldahl LC, Park M, Miller JR, Moon RT.; ''The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape.''; PubMed Europe PMC Scholia
  103. Guo N, Hawkins C, Nathans J.; ''Frizzled6 controls hair patterning in mice.''; PubMed Europe PMC Scholia
  104. Liu Y, Shi J, Lu CC, Wang ZB, Lyuksyutova AI, Song XJ, Zou Y.; ''Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract.''; PubMed Europe PMC Scholia
  105. Wang MT, Holderfield M, Galeas J, Delrosario R, To MD, Balmain A, McCormick F.; ''K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.''; PubMed Europe PMC Scholia
  106. Li X, Roszko I, Sepich DS, Ni M, Hamm HE, Marlow FL, Solnica-Krezel L.; ''Gpr125 modulates Dishevelled distribution and planar cell polarity signaling.''; PubMed Europe PMC Scholia
  107. De A.; ''Wnt/Ca2+ signaling pathway: a brief overview.''; PubMed Europe PMC Scholia
  108. Wang Y, Guo N, Nathans J.; ''The role of Frizzled3 and Frizzled6 in neural tube closure and in the planar polarity of inner-ear sensory hair cells.''; PubMed Europe PMC Scholia
  109. Maung SM, Jenny A.; ''Planar cell polarity in Drosophila.''; PubMed Europe PMC Scholia
  110. Gao B.; ''Wnt regulation of planar cell polarity (PCP).''; PubMed Europe PMC Scholia
  111. Wong HC, Bourdelas A, Krauss A, Lee HJ, Shao Y, Wu D, Mlodzik M, Shi DL, Zheng J.; ''Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled.''; PubMed Europe PMC Scholia
  112. Yamamoto H, Kitadai Y, Yamamoto H, Oue N, Ohdan H, Yasui W, Kikuchi A.; ''Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.''; PubMed Europe PMC Scholia
  113. Voges D, Zwickl P, Baumeister W.; ''The 26S proteasome: a molecular machine designed for controlled proteolysis.''; PubMed Europe PMC Scholia
  114. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, Matsumoto K.; ''The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF.''; PubMed Europe PMC Scholia
  115. Chen J, Zhang M.; ''The Par3/Par6/aPKC complex and epithelial cell polarity.''; PubMed Europe PMC Scholia
  116. Bazhin AV, Tambor V, Dikov B, Philippov PP, Schadendorf D, Eichmüller SB.; ''cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca(2+) homeostasis in melanoma cells.''; PubMed Europe PMC Scholia
  117. Aspenström P.; ''Formin-binding proteins: modulators of formin-dependent actin polymerization.''; PubMed Europe PMC Scholia
  118. Hanaki H, Yamamoto H, Sakane H, Matsumoto S, Ohdan H, Sato A, Kikuchi A.; ''An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.''; PubMed Europe PMC Scholia
  119. Gao B, Song H, Bishop K, Elliot G, Garrett L, English MA, Andre P, Robinson J, Sood R, Minami Y, Economides AN, Yang Y.; ''Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2.''; PubMed Europe PMC Scholia
  120. Kim W, Kim M, Jho EH.; ''Wnt/β-catenin signalling: from plasma membrane to nucleus.''; PubMed Europe PMC Scholia
  121. Čajánek L, Ganji RS, Henriques-Oliveira C, Theofilopoulos S, Koník P, Bryja V, Arenas E.; ''Tiam1 regulates the Wnt/Dvl/Rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons.''; PubMed Europe PMC Scholia
  122. Heasman SJ, Ridley AJ.; ''Mammalian Rho GTPases: new insights into their functions from in vivo studies.''; PubMed Europe PMC Scholia
  123. Hofmann F.; ''The biology of cyclic GMP-dependent protein kinases.''; PubMed Europe PMC Scholia
  124. Park TJ, Gray RS, Sato A, Habas R, Wallingford JB.; ''Subcellular localization and signaling properties of dishevelled in developing vertebrate embryos.''; PubMed Europe PMC Scholia
  125. Wang H, Lee Y, Malbon CC.; ''PDE6 is an effector for the Wnt/Ca2+/cGMP-signalling pathway in development.''; PubMed Europe PMC Scholia
  126. May-Simera H, Kelley MW.; ''Planar cell polarity in the inner ear.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114849view16:35, 25 January 2021ReactomeTeamReactome version 75
113295view11:36, 2 November 2020ReactomeTeamReactome version 74
112507view15:46, 9 October 2020ReactomeTeamReactome version 73
101419view11:30, 1 November 2018ReactomeTeamreactome version 66
100957view21:07, 31 October 2018ReactomeTeamreactome version 65
100494view19:41, 31 October 2018ReactomeTeamreactome version 64
100039view16:24, 31 October 2018ReactomeTeamreactome version 63
99592view14:58, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
99211view12:43, 31 October 2018ReactomeTeamreactome version 62
93927view13:45, 16 August 2017ReactomeTeamreactome version 61
93513view11:25, 9 August 2017ReactomeTeamreactome version 61
87134view18:50, 18 July 2016MkutmonOntology Term : 'PW:0000008' removed !
87133view18:50, 18 July 2016MkutmonOntology Term : 'Wnt signaling, non-canonical pathway' added !
87093view14:28, 18 July 2016MkutmonOntology Term : 'Wnt signaling pathway' added !
86609view09:22, 11 July 2016ReactomeTeamreactome version 56
83448view12:25, 18 November 2015ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
'canonical' WNT

target gene

transcripts		ComplexR-HSA-4411358 (Reactome)
'canonical' WNT target genesComplexR-HSA-4411390 (Reactome)
26S proteasomeComplexR-HSA-68819 (Reactome)
ADPMetaboliteCHEBI:16761 (ChEBI)
AP2A1 ProteinO95782 (Uniprot-TrEMBL)
AP2A2(1-939) ProteinO94973 (Uniprot-TrEMBL)
AP2B1 ProteinP63010 (Uniprot-TrEMBL)
AP2M1 ProteinQ96CW1 (Uniprot-TrEMBL)
AP2S1 ProteinP53680 (Uniprot-TrEMBL)
ARRB2 ProteinP32121 (Uniprot-TrEMBL)
ARRB2ProteinP32121 (Uniprot-TrEMBL)
ATPMetaboliteCHEBI:15422 (ChEBI)
AXIN2 gene ProteinENSG00000168646 (Ensembl)
AXIN2 mRNA ProteinENST00000307078 (Ensembl)
Activated Protein

kinase C (alpha, beta, gamma

isoforms)		ComplexR-HSA-425832 (Reactome)
CALM1 ProteinP62158 (Uniprot-TrEMBL)
CALM1:4xCa2+ComplexR-HSA-74294 (Reactome)
CAMK2:CaMComplexR-HSA-4332345 (Reactome)
CAMK2A ProteinQ9UQM7 (Uniprot-TrEMBL)
CAMK2AComplexR-HSA-4332343 (Reactome)
CLTA ProteinP09496 (Uniprot-TrEMBL)
CLTB ProteinP09497 (Uniprot-TrEMBL)
CLTC ProteinQ00610 (Uniprot-TrEMBL)
CTNNB1 ProteinP35222 (Uniprot-TrEMBL)
Ca2+ MetaboliteCHEBI:29108 (ChEBI)
Ca2+MetaboliteCHEBI:29108 (ChEBI)
Calcineurin (CaN)ComplexR-HSA-2025977 (Reactome)
Calcineurin:Calmodulin (CaN:CaM)ComplexR-HSA-2025947 (Reactome)
DAAM1 ProteinQ9Y4D1 (Uniprot-TrEMBL)
DAAM1ProteinQ9Y4D1 (Uniprot-TrEMBL)
DAG MetaboliteCHEBI:17815 (ChEBI)
DAGMetaboliteCHEBI:17815 (ChEBI)
DVL2 ProteinO14641 (Uniprot-TrEMBL)
DVL2ProteinO14641 (Uniprot-TrEMBL)
EIF2C1 ProteinQ9UL18 (Uniprot-TrEMBL)
EIF2C2 ProteinQ9UKV8 (Uniprot-TrEMBL)
EIF2C3 ProteinQ9H9G7 (Uniprot-TrEMBL)
EIF2C4 ProteinQ9HCK5 (Uniprot-TrEMBL)
FZD1 ProteinQ9UP38 (Uniprot-TrEMBL)
FZD2 ProteinQ14332 (Uniprot-TrEMBL)
FZD2/FZD5/ROR2ComplexR-HSA-5140732 (Reactome)
FZD3 ProteinQ9NPG1 (Uniprot-TrEMBL)
FZD3ProteinQ9NPG1 (Uniprot-TrEMBL)
FZD4 ProteinQ9ULV1 (Uniprot-TrEMBL)
FZD4ProteinQ9ULV1 (Uniprot-TrEMBL)
FZD5 ProteinQ13467 (Uniprot-TrEMBL)
FZD6 ProteinO60353 (Uniprot-TrEMBL)
FZD7 ProteinO75084 (Uniprot-TrEMBL)
FZD8 ProteinQ9H461 (Uniprot-TrEMBL)
Fe3+ MetaboliteCHEBI:29034 (ChEBI)
G-protein

beta-gamma:PLC beta

1/2/3		ComplexR-HSA-398037 (Reactome)
G-protein alpha (o/t2)ComplexR-HSA-3965383 (Reactome)
G-protein beta-gamma complexComplexR-HSA-167434 (Reactome)
GDP MetaboliteCHEBI:17552 (ChEBI)
GDPMetaboliteCHEBI:17552 (ChEBI)
GMPMetaboliteCHEBI:17345 (ChEBI)
GNAO1 ProteinP09471 (Uniprot-TrEMBL)
GNAT2 ProteinP19087 (Uniprot-TrEMBL)
GNAT2:GTPComplexR-HSA-4085966 (Reactome)
GNAT2:PDE6ComplexR-HSA-4085970 (Reactome)
GNB1 ProteinP62873 (Uniprot-TrEMBL)
GNB2 ProteinP62879 (Uniprot-TrEMBL)
GNB3 ProteinP16520 (Uniprot-TrEMBL)
GNB4 ProteinQ9HAV0 (Uniprot-TrEMBL)
GNB5 ProteinO14775 (Uniprot-TrEMBL)
GNG10 ProteinP50151 (Uniprot-TrEMBL)
GNG11 ProteinP61952 (Uniprot-TrEMBL)
GNG12 ProteinQ9UBI6 (Uniprot-TrEMBL)
GNG13 ProteinQ9P2W3 (Uniprot-TrEMBL)
GNG2 ProteinP59768 (Uniprot-TrEMBL)
GNG3 ProteinP63215 (Uniprot-TrEMBL)
GNG4 ProteinP50150 (Uniprot-TrEMBL)
GNG5 ProteinP63218 (Uniprot-TrEMBL)
GNG7 ProteinO60262 (Uniprot-TrEMBL)
GNG8 ProteinQ9UK08 (Uniprot-TrEMBL)
GNGT1 ProteinP63211 (Uniprot-TrEMBL)
GNGT2 ProteinO14610 (Uniprot-TrEMBL)
GTP MetaboliteCHEBI:15996 (ChEBI)
GTPMetaboliteCHEBI:15996 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
Heterotrimeric

G-protein (o/t2)

(inactive)		ComplexR-HSA-3965398 (Reactome)
I(1,4,5)P3 MetaboliteCHEBI:16595 (ChEBI)
I(1,4,5)P3MetaboliteCHEBI:16595 (ChEBI)
IP3 receptor homotetramerComplexR-HSA-169686 (Reactome)
ITPR1 ProteinQ14643 (Uniprot-TrEMBL)
ITPR2 ProteinQ14571 (Uniprot-TrEMBL)
ITPR3 ProteinQ14573 (Uniprot-TrEMBL)
ITPR:I(1,4,5)P3 tetramerComplexR-HSA-169696 (Reactome)
LEF1 ProteinQ9UJU2 (Uniprot-TrEMBL)
MAP3K7 ProteinO43318 (Uniprot-TrEMBL)
MAP3K7ProteinO43318 (Uniprot-TrEMBL)
MOV10 ProteinQ9HCE1 (Uniprot-TrEMBL)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
N4GlycoAsn-PalmS WNT5A(36-380)ProteinP41221 (Uniprot-TrEMBL)
N4GlycoAsn-PalmS WNT5A:ROR2:VANGL2ComplexR-HSA-4551543 (Reactome)
N4GlycoAsn-PalmS WNT5A:ROR2:p-VANGL2ComplexR-HSA-4551546 (Reactome)
N4GlycoAsn-PalmS WNT1 ProteinP04628 (Uniprot-TrEMBL)
N4GlycoAsn-PalmS WNT11 ProteinO96014 (Uniprot-TrEMBL)
N4GlycoAsn-PalmS WNT4 ProteinP56705 (Uniprot-TrEMBL)
N4GlycoAsn-PalmS WNT5A(36-380) ProteinP41221 (Uniprot-TrEMBL)
N4GlycoAsn-PalmS WNT5B ProteinQ9H1J7 (Uniprot-TrEMBL)
N4GlycoAsn-PalmS-WNT5A:FZD4ComplexR-HSA-5099901 (Reactome)
N4GlycoAsn-PalmS-WNT5A:RYK:VANGL2ComplexR-HSA-4551548 (Reactome)
NFATC1:CaN:CaMComplexR-HSA-4551448 (Reactome)
NFATC1:CaN:CaMComplexR-HSA-4551463 (Reactome)
NLK mRNA ProteinENST00000407008 (Ensembl)
NLK mRNA:miR-92b RISCComplexR-HSA-4518571 (Reactome)
NLK mRNARnaENST00000407008 (Ensembl)
NLKProteinQ9UBE8 (Uniprot-TrEMBL)
PARD6A ProteinQ9NPB6 (Uniprot-TrEMBL)
PARD6A:p-DVL2ComplexR-HSA-5099880 (Reactome)
PARD6A:pp-DVL2:SMURFComplexR-HSA-4608811 (Reactome)
PARD6A:pp-DVL2ComplexR-HSA-4608813 (Reactome)
PCP pathway FZDsComplexR-HSA-3858485 (Reactome)
PCP pathway WNTsComplexR-HSA-3858483 (Reactome)
PDE6A ProteinP16499 (Uniprot-TrEMBL)
PDE6B ProteinP35913 (Uniprot-TrEMBL)
PDE6G ProteinP18545 (Uniprot-TrEMBL)
PDE6ComplexR-HSA-4085971 (Reactome)
PFN1 ProteinP07737 (Uniprot-TrEMBL)
PFN1ProteinP07737 (Uniprot-TrEMBL)
PI(4,5)P2MetaboliteCHEBI:18348 (ChEBI)
PLC-beta 1/2/3ComplexR-HSA-425749 (Reactome)
PLCB1 ProteinQ9NQ66 (Uniprot-TrEMBL)
PLCB2 ProteinQ00722 (Uniprot-TrEMBL)
PLCB3 ProteinQ01970 (Uniprot-TrEMBL)
PPP3CA ProteinQ08209 (Uniprot-TrEMBL)
PPP3CB ProteinP16298 (Uniprot-TrEMBL)
PPP3R1 ProteinP63098 (Uniprot-TrEMBL)
PRICKLE1ProteinQ96MT3 (Uniprot-TrEMBL)
PRKCA ProteinP17252 (Uniprot-TrEMBL)
PRKCB ProteinP05771 (Uniprot-TrEMBL)
PRKCG ProteinP05129 (Uniprot-TrEMBL)
PRKG dimerComplexR-HSA-4551462 (Reactome)
PRKG homodimer:cGMPComplexR-HSA-4551456 (Reactome)
PRKG1 ProteinQ13976 (Uniprot-TrEMBL)
PRKG2 ProteinQ13237 (Uniprot-TrEMBL)
PSMA1 ProteinP25786 (Uniprot-TrEMBL)
PSMA2 ProteinP25787 (Uniprot-TrEMBL)
PSMA3 ProteinP25788 (Uniprot-TrEMBL)
PSMA4 ProteinP25789 (Uniprot-TrEMBL)
PSMA5 ProteinP28066 (Uniprot-TrEMBL)
PSMA6 ProteinP60900 (Uniprot-TrEMBL)
PSMA7 ProteinO14818 (Uniprot-TrEMBL)
PSMA8 ProteinQ8TAA3 (Uniprot-TrEMBL)
PSMB1 ProteinP20618 (Uniprot-TrEMBL)
PSMB10 ProteinP40306 (Uniprot-TrEMBL)
PSMB11 ProteinA5LHX3 (Uniprot-TrEMBL)
PSMB2 ProteinP49721 (Uniprot-TrEMBL)
PSMB3 ProteinP49720 (Uniprot-TrEMBL)
PSMB4 ProteinP28070 (Uniprot-TrEMBL)
PSMB5 ProteinP28074 (Uniprot-TrEMBL)
PSMB6 ProteinP28072 (Uniprot-TrEMBL)
PSMB7 ProteinQ99436 (Uniprot-TrEMBL)
PSMB8 ProteinP28062 (Uniprot-TrEMBL)
PSMB9 ProteinP28065 (Uniprot-TrEMBL)
PSMC1 ProteinP62191 (Uniprot-TrEMBL)
PSMC2 ProteinP35998 (Uniprot-TrEMBL)
PSMC3 ProteinP17980 (Uniprot-TrEMBL)
PSMC4 ProteinP43686 (Uniprot-TrEMBL)
PSMC5 ProteinP62195 (Uniprot-TrEMBL)
PSMC6 ProteinP62333 (Uniprot-TrEMBL)
PSMD1 ProteinQ99460 (Uniprot-TrEMBL)
PSMD10 ProteinO75832 (Uniprot-TrEMBL)
PSMD11 ProteinO00231 (Uniprot-TrEMBL)
PSMD12 ProteinO00232 (Uniprot-TrEMBL)
PSMD13 ProteinQ9UNM6 (Uniprot-TrEMBL)
PSMD14 ProteinO00487 (Uniprot-TrEMBL)
PSMD2 ProteinQ13200 (Uniprot-TrEMBL)
PSMD3 ProteinO43242 (Uniprot-TrEMBL)
PSMD4 ProteinP55036 (Uniprot-TrEMBL)
PSMD5 ProteinQ16401 (Uniprot-TrEMBL)
PSMD6 ProteinQ15008 (Uniprot-TrEMBL)
PSMD7 ProteinP51665 (Uniprot-TrEMBL)
PSMD8 ProteinP48556 (Uniprot-TrEMBL)
PSMD9 ProteinO00233 (Uniprot-TrEMBL)
PSME1 ProteinQ06323 (Uniprot-TrEMBL)
PSME2 ProteinQ9UL46 (Uniprot-TrEMBL)
PSME3 ProteinP61289 (Uniprot-TrEMBL)
PSME4 ProteinQ14997 (Uniprot-TrEMBL)
PSMF1 ProteinQ92530 (Uniprot-TrEMBL)
Phosphatidylserine MetaboliteCHEBI:18303 (ChEBI)
PhosphatidylserineMetaboliteCHEBI:18303 (ChEBI)
PiMetaboliteCHEBI:18367 (ChEBI)
RAC1 ProteinP63000 (Uniprot-TrEMBL)
RAC2 ProteinP15153 (Uniprot-TrEMBL)
RAC3 ProteinP60763 (Uniprot-TrEMBL)
RAC:GTPComplexR-HSA-3858468 (Reactome)
RHOA ProteinP61586 (Uniprot-TrEMBL)
RHOA:GTP:Mg2+ComplexR-HSA-3858473 (Reactome)
ROR1 ProteinQ01973 (Uniprot-TrEMBL)
ROR2 ProteinQ01974 (Uniprot-TrEMBL)
ROR2ProteinQ01974 (Uniprot-TrEMBL)
RPS27A(1-76) ProteinP62979 (Uniprot-TrEMBL)
RYK ProteinP34925 (Uniprot-TrEMBL)
RYKProteinP34925 (Uniprot-TrEMBL)
SCRIB ProteinQ14160 (Uniprot-TrEMBL)
SCRIBProteinQ14160 (Uniprot-TrEMBL)
SMURF1 ProteinQ9HCE7 (Uniprot-TrEMBL)
SMURF2 ProteinQ9HAU4 (Uniprot-TrEMBL)
SMURFComplexR-HSA-173533 (Reactome)
TCF dependent

signaling in

response to WNT		PathwayR-HSA-201681 (Reactome) 19 WNT ligands and 10 FZD receptors have been identified in human cells; interactions amongst these ligands and receptors vary in a developmental and tissue-specific manner and lead to activation of so-called 'canonical' and 'non-canonical' WNT signaling. In the canonical WNT signaling pathway, binding of a WNT ligand to the Frizzled (FZD) and lipoprotein receptor-related protein (LRP) receptors results in the inactivation of the destruction complex, the stabilization and nuclear translocation of beta-catenin and subsequent activation of T-cell factor/lymphoid enhancing factor (TCF/LEF)-dependent transcription. Transcriptional activation in response to canonical WNT signaling controls processes such as cell fate, proliferation and self renewal of stem cells, as well as contributing to oncogenesis (reviewed in MacDonald et al, 2009; Saito-Diaz et al, 2013; Kim et al, 2013).
TCF/LEF:CTNNB1ComplexR-HSA-4411397 (Reactome)
TCF7 ProteinP36402 (Uniprot-TrEMBL)
TCF7L1 ProteinQ9HCS4 (Uniprot-TrEMBL)
TCF7L2 ProteinQ9NQB0 (Uniprot-TrEMBL)
TNRC6A ProteinQ8NDV7 (Uniprot-TrEMBL)
TNRC6B ProteinQ9UPQ9 (Uniprot-TrEMBL)
TNRC6C ProteinQ9HCJ0 (Uniprot-TrEMBL)
UBA52(1-76) ProteinP62987 (Uniprot-TrEMBL)
UBB(1-76) ProteinP0CG47 (Uniprot-TrEMBL)
UBB(153-228) ProteinP0CG47 (Uniprot-TrEMBL)
UBB(77-152) ProteinP0CG47 (Uniprot-TrEMBL)
UBC(1-76) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(153-228) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(229-304) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(305-380) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(381-456) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(457-532) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(533-608) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(609-684) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(77-152) ProteinP0CG48 (Uniprot-TrEMBL)
UbiquitinComplexR-HSA-68524 (Reactome)
VANGL2 ProteinQ9ULK5 (Uniprot-TrEMBL)
VANGL2:SCRIB:FZD3ComplexR-HSA-4608864 (Reactome)
VANGL2:SCRIBComplexR-HSA-4608863 (Reactome)
VANGL2ProteinQ9ULK5 (Uniprot-TrEMBL)
WNT/Ca2+ FZDsComplexR-HSA-3965381 (Reactome)
WNT5A-binding FZDsComplexR-HSA-5140744 (Reactome)
WNT5A/11:FZD:G-protein (alpha o/t2) activeComplexR-HSA-3965394 (Reactome)
WNT5A/11:FZD:G-protein (alpha o/t2) inactiveComplexR-HSA-3965393 (Reactome)
WNT5A/11:FZDComplexR-HSA-3965390 (Reactome)
WNT5A/WNT11ComplexR-HSA-3965385 (Reactome)
WNT5A:FZD4:DVL2ComplexR-HSA-5138436 (Reactome)
WNT5A:FZD4:p-DVL2:AP-2:clathrinComplexR-HSA-5138458 (Reactome)
WNT5A:FZD4:p-DVL2:ARRB2:AP-2:clathrinComplexR-HSA-5138437 (Reactome)
WNT5A:FZD4:p-DVL2ComplexR-HSA-5138442 (Reactome)
WNT5A:FZDComplexR-HSA-4608830 (Reactome)
WNT5A:FZDs/RORComplexR-HSA-5140740 (Reactome)
WNT5A:FZDs/RORComplexR-HSA-5140748 (Reactome)
WNT:FZD:pDVLComplexR-HSA-3858484 (Reactome)
WNT:FZDComplexR-HSA-3858486 (Reactome)
Zn2+ MetaboliteCHEBI:29105 (ChEBI)
activated PKC alphaComplexR-HSA-4332385 (Reactome)
cGMP MetaboliteCHEBI:16356 (ChEBI)
cGMPMetaboliteCHEBI:16356 (ChEBI)
clathrin:AP-2ComplexR-HSA-5138434 (Reactome)
miR-92b RISCComplexR-HSA-4518568 (Reactome)
miR-92b ProteinmiR0003560 (miRBase mature sequence)
p-12S-NFATC1ProteinO95644 (Uniprot-TrEMBL)
p-DVL2 ProteinO14641 (Uniprot-TrEMBL)
p-DVL3 ProteinQ92997 (Uniprot-TrEMBL)
p-DVLComplexR-HSA-3858479 (Reactome)
p-S-DVL1 ProteinO14640 (Uniprot-TrEMBL)
p-S257-NFATC1 ProteinO95644 (Uniprot-TrEMBL)
p-T187-MAP3K7ProteinO43318 (Uniprot-TrEMBL)
p-T286 CAMK2:CaMComplexR-HSA-4332348 (Reactome)
p-T286,305,306-CAMK2:MAP3K7ComplexR-HSA-4332361 (Reactome)
p-T286,T305,T306-CAMK2A ProteinQ9UQM7 (Uniprot-TrEMBL)
p-T286,T305,T306-CAMK2AComplexR-HSA-4332355 (Reactome)
p-T286-CAMK2A ProteinQ9UQM7 (Uniprot-TrEMBL)
p-T298-NLK ProteinQ9UBE8 (Uniprot-TrEMBL)
p-TCF/LEF:CTNNB1ComplexR-HSA-4411380 (Reactome)
pS5,S82,S84-VANGL2 ProteinQ9ULK5 (Uniprot-TrEMBL)
pT155,S166-LEF1 ProteinQ9UJU2 (Uniprot-TrEMBL)
pT201,T212-TCF7L2 ProteinQ9NQB0 (Uniprot-TrEMBL)
pT298-NLK dimerComplexR-HSA-4411348 (Reactome)
pT298-NLK dimerComplexR-HSA-4411401 (Reactome)
pT497,T638,S657-PRKCA ProteinP17252 (Uniprot-TrEMBL)
pT497,T638,S657-PRKCAProteinP17252 (Uniprot-TrEMBL)
pp-DVL1 ProteinO14640 (Uniprot-TrEMBL)
pp-DVL2 ProteinO14641 (Uniprot-TrEMBL)
pp-DVL3 ProteinQ92997 (Uniprot-TrEMBL)
pp-DVLComplexR-HSA-3858467 (Reactome)
ppDVL:DAAM1:PFN1ComplexR-HSA-3965386 (Reactome)
ppDVL:DAAM1:RHOA:GTPComplexR-HSA-3858474 (Reactome)
ppDVL:DAAM1ComplexR-HSA-3858472 (Reactome)
ppDVL:RAC:GTPComplexR-HSA-3858469 (Reactome)
ub-PRICKLE1ProteinQ96MT3 (Uniprot-TrEMBL)
unknown kinaseR-HSA-451336 (Reactome)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
'canonical' WNT

target gene

transcripts		ArrowR-HSA-4411365 (Reactome)
'canonical' WNT target genesR-HSA-4411365 (Reactome)
26S proteasomemim-catalysisR-HSA-4608855 (Reactome)
ADPArrowR-HSA-3858480 (Reactome)
ADPArrowR-HSA-4332358 (Reactome)
ADPArrowR-HSA-4332363 (Reactome)
ADPArrowR-HSA-4332388 (Reactome)
ADPArrowR-HSA-4411383 (Reactome)
ADPArrowR-HSA-4411402 (Reactome)
ADPArrowR-HSA-4551570 (Reactome)
ADPArrowR-HSA-4608825 (Reactome)
ADPArrowR-HSA-5138432 (Reactome)
ARRB2ArrowR-HSA-5138459 (Reactome)
ARRB2R-HSA-5138433 (Reactome)
ATPR-HSA-3858480 (Reactome)
ATPR-HSA-4332358 (Reactome)
ATPR-HSA-4332363 (Reactome)
ATPR-HSA-4332388 (Reactome)
ATPR-HSA-4411383 (Reactome)
ATPR-HSA-4411402 (Reactome)
ATPR-HSA-4551570 (Reactome)
ATPR-HSA-4608825 (Reactome)
ATPR-HSA-5138432 (Reactome)
Activated Protein

kinase C (alpha, beta, gamma

isoforms)		mim-catalysisR-HSA-5138432 (Reactome)
CALM1:4xCa2+ArrowR-HSA-4332358 (Reactome)
CALM1:4xCa2+R-HSA-2730872 (Reactome)
CALM1:4xCa2+R-HSA-4332359 (Reactome)
CAMK2:CaMArrowR-HSA-4332359 (Reactome)
CAMK2:CaMR-HSA-4332363 (Reactome)
CAMK2:CaMmim-catalysisR-HSA-4332363 (Reactome)
CAMK2AR-HSA-4332359 (Reactome)
Ca2+ArrowR-HSA-4420052 (Reactome)
Ca2+R-HSA-2730872 (Reactome)
Ca2+R-HSA-4332390 (Reactome)
Ca2+R-HSA-4420052 (Reactome)
Calcineurin (CaN)R-HSA-2730872 (Reactome)
Calcineurin:Calmodulin (CaN:CaM)ArrowR-HSA-2730872 (Reactome)
Calcineurin:Calmodulin (CaN:CaM)R-HSA-4551451 (Reactome)
DAAM1R-HSA-3858489 (Reactome)
DAGArrowR-HSA-398193 (Reactome)
DAGR-HSA-4332390 (Reactome)
DVL2R-HSA-5138441 (Reactome)
FZD2/FZD5/ROR2R-HSA-5140741 (Reactome)
FZD3R-HSA-4608866 (Reactome)
FZD4R-HSA-5099899 (Reactome)
G-protein

beta-gamma:PLC beta

1/2/3		ArrowR-HSA-398040 (Reactome)
G-protein

beta-gamma:PLC beta

1/2/3		mim-catalysisR-HSA-398193 (Reactome)
G-protein alpha (o/t2)ArrowR-HSA-3965447 (Reactome)
G-protein beta-gamma complexArrowR-HSA-3965447 (Reactome)
G-protein beta-gamma complexR-HSA-398040 (Reactome)
GDPArrowR-HSA-3965444 (Reactome)
GMPArrowR-HSA-4086392 (Reactome)
GNAT2:GTPR-HSA-4086393 (Reactome)
GNAT2:PDE6ArrowR-HSA-4086393 (Reactome)
GNAT2:PDE6mim-catalysisR-HSA-4086392 (Reactome)
GTPR-HSA-3965444 (Reactome)
H2OR-HSA-4086392 (Reactome)
H2OR-HSA-4551451 (Reactome)
Heterotrimeric

G-protein (o/t2)

(inactive)		R-HSA-3965441 (Reactome)
I(1,4,5)P3ArrowR-HSA-398193 (Reactome)
I(1,4,5)P3R-HSA-169680 (Reactome)
IP3 receptor homotetramerR-HSA-169680 (Reactome)
ITPR:I(1,4,5)P3 tetramerArrowR-HSA-169680 (Reactome)
ITPR:I(1,4,5)P3 tetramermim-catalysisR-HSA-4420052 (Reactome)
MAP3K7R-HSA-4332356 (Reactome)
N4GlycoAsn-PalmS WNT5A(36-380)R-HSA-4551555 (Reactome)
N4GlycoAsn-PalmS WNT5A(36-380)R-HSA-4551571 (Reactome)
N4GlycoAsn-PalmS WNT5A(36-380)R-HSA-5099886 (Reactome)
N4GlycoAsn-PalmS WNT5A(36-380)R-HSA-5099899 (Reactome)
N4GlycoAsn-PalmS WNT5A(36-380)R-HSA-5140741 (Reactome)
N4GlycoAsn-PalmS WNT5A:ROR2:VANGL2ArrowR-HSA-4551571 (Reactome)
N4GlycoAsn-PalmS WNT5A:ROR2:VANGL2R-HSA-4551570 (Reactome)
N4GlycoAsn-PalmS WNT5A:ROR2:p-VANGL2ArrowR-HSA-4551570 (Reactome)
N4GlycoAsn-PalmS-WNT5A:FZD4ArrowR-HSA-5099899 (Reactome)
N4GlycoAsn-PalmS-WNT5A:FZD4R-HSA-5138441 (Reactome)
N4GlycoAsn-PalmS-WNT5A:RYK:VANGL2ArrowR-HSA-4551555 (Reactome)
NFATC1:CaN:CaMArrowR-HSA-4551451 (Reactome)
NFATC1:CaN:CaMArrowR-HSA-4551465 (Reactome)
NFATC1:CaN:CaMR-HSA-4551465 (Reactome)
NLK mRNA:miR-92b RISCArrowR-HSA-4518575 (Reactome)
NLK mRNA:miR-92b RISCTBarR-HSA-4518585 (Reactome)
NLK mRNAR-HSA-4518575 (Reactome)
NLK mRNAR-HSA-4518585 (Reactome)
NLKArrowR-HSA-4518585 (Reactome)
NLKR-HSA-4411402 (Reactome)
NLKmim-catalysisR-HSA-4411402 (Reactome)
PARD6A:p-DVL2R-HSA-4608825 (Reactome)
PARD6A:pp-DVL2:SMURFArrowR-HSA-4608854 (Reactome)
PARD6A:pp-DVL2:SMURFmim-catalysisR-HSA-4608852 (Reactome)
PARD6A:pp-DVL2ArrowR-HSA-4608825 (Reactome)
PARD6A:pp-DVL2R-HSA-4608854 (Reactome)
PCP pathway FZDsR-HSA-3858491 (Reactome)
PCP pathway WNTsR-HSA-3858491 (Reactome)
PDE6R-HSA-4086393 (Reactome)
PFN1R-HSA-3965450 (Reactome)
PI(4,5)P2R-HSA-398193 (Reactome)
PLC-beta 1/2/3R-HSA-398040 (Reactome)
PRICKLE1R-HSA-4608852 (Reactome)
PRKG dimerR-HSA-4551453 (Reactome)
PRKG homodimer:cGMPArrowR-HSA-4551453 (Reactome)
PhosphatidylserineR-HSA-4332390 (Reactome)
PiArrowR-HSA-4551451 (Reactome)
R-HSA-169680 (Reactome) The IP3 receptor (IP3R) is an IP3-gated calcium channel. It is a large, homotetrameric protein, similar to other calcium channel proteins such as ryanodine. The four subunits form a 'four-leafed clover' structure arranged around the central calcium channel. Binding of ligands such as IP3 results in conformational changes in the receptor's structure that leads to channel opening.
R-HSA-2730872 (Reactome) Calcineurin (CaN), also called protein phosphatase 2B (PP2B), is a calcium/Calmodulin (CaM)-dependent serine/threonine protein phosphatase. It exists as a heterodimer consisting of CaM-binding catalytic subunit CaN A chain and a Ca+2 binding regulatory CaN B chain. At low calcium concentrations, CaN exists in an inactive state, where the autoinhibitory domain (AID) binds to the active-site cleft. Upon an increase in calcium concentration CaM binds to Ca+2 ions and gets activated. Active CaM binds to CaN regulatory domain (RD) and this causes release of the AID and activation of the phosphatase (Rumi-Masante et al. 2012). Binding of calcium to CaN B regulatory chain also causes a conformational change of the RD of CaN A chain (Yang & Klee 2000).
R-HSA-3858475 (Reactome) WNT-dependent activation of DVL induces the activation of RAC and the formation of a RAC-DVL complex in HEK293 cells (Habas et al, 2003). Activation of RAC and stimulation of PCP/CE signaling depends on the DEP but not the DIX domain of DVL, consistent with earlier reports (Axelrod et al, 1998; Boutros et al, 1998, Habas et al, 2001, Habas et al, 2003). There are conflicting reports regarding the requirement for the DVL PDZ domain in the WNT-dependent activation of RAC (Habas et al, 2003; Cajanek et al, 2013). Activation of RAC almost certainly involves a RAC-specific GEF activity, potentially associated with DVL. In dopaminergic neurons, TIAM1 has been identified as the GEF for WNT5a- and DVL-dependent activation of RAC (Cajanek et al, 2013), however it is not clear whether this is generally true in other cell types and for other WNT ligands. In some cases, RAC activation correlates with activation of the downstream effector c-Jun N terminal kinase (JNK). This is thought to regulate reorganization of the cytoskeleton, however the mechanism of JNK activation is unknown. In other cases, JNK activation appears to be dispensable to the WNT response (Yamanaka et al, 2002; Habas et al, 2003; Rosso et al, 2005; reviewed in Heaseman and Ridley, 2008; Lai et al, 2009)
R-HSA-3858480 (Reactome) In response to WNT signaling, DVL proteins are phosphorylated within the C-terminal 143 amino-acids. This site appears to be common for both canonical and non-canonical WNT signaling as a similar phosphorylation pattern is observed upon stimulation with WNT1 and WNT5A and no discernable supershifted phosphoform is detected upon simultaneous treatment with both ligands (Gonzalez-Sancho et al, 2004). The kinase responsible for this phosphorylation has not been identified, although CK2, CK1 delta and epsilon and PAR1 have all been shown to phosphorylate DVL in vitro and in vivo under varying conditions (reviewed in Gao and Chen, 2010). WNT3a or WNT5a-induced phosphorylation sites are Ser594, Thr595 and Ser597 in Dvl2 (Gonzalez-Sancho et al, 2013).
R-HSA-3858482 (Reactome) The DEP domain of DVL is required both for PCP signaling and for membrane localization upon WNT activation (Boutros et al, 1998; Axelrod et al, 2001; Rothbacher et al, 2000, Wong et al, 2000; Park et al, 2005; Witzel et al, 2006). Although DVL interacts with FZD through its PDZ domain, disruption of this binding interface does not interfere with non-canonical signaling (Wong et al, 2003); membrane recruitment of DVL and establishment of PCP may also rely on other interacting partners (Lee et al, 2007; Li et al, 2013).
R-HSA-3858489 (Reactome) DAAM1 (Dishevelled-associated activator of morphogenesis) is a formin-homology protein that was identified in a yeast two-hybrid screen for interactors with the DVL PDZ domain (Habas et al, 2001). FH proteins play a well-characterized role in regulating cytoskeletal reorganization (reviewed in Aspenstrom, 2010). DAAM1 contains an N-terminal GTPase binding domain (GBD), two central proline-rich FH domains and a C-terminal diaphanous autoinhibitory domain (DAD). In the absence of a WNT signal, DAAM1 exists in an autoinhibited conformation mediated by an intramolecular interaction between the DBD and DAD regions (Habas et al, 2001; Liu et al, 2007). Upon WNT signaling, a direct interaction between the DAD of DAAM1 and the PDZ domain of DVL relieves the autoinhibition. In the activated conformation, DAAM1 may undergo FH-dependent oligomerization and had been shown to recruit RHOA in a GBD-dependent manner (Habas et al, 2001; Liu et al, 2007).
R-HSA-3858491 (Reactome) Detailed biochemical analyses of all the WNT ligand-receptor interactions that initiate the planar cell polarity pathway are not fully elucidated (reviewed in Gao et al, 2012). In Xenopus embryos, direct interaction between Wnt11 and Fzd7 has been shown to be required for convergent extension during gastrulation (Djiane et al, 2000), In mouse Fzd 1, 2, 3 and 6 have known roles in neural tube closure and cochlear hair orientation, two typical PCP processes, although the initiating ligands have not been clearly defined (Guo et al, 2004; Wang et al, 2006; Yu et al, 2010). Similarly, vertebrate Wnt5a and Wnt11 are implicated in numerous PCP processes including limb bud formation, neural tube closure, hair orientation and cytoskeletal rearrangements, but a direct interaction with a FZD receptor has not been demonstrated in all cases (Gao et al, 2011; Qian et al, 2007).
R-HSA-3858495 (Reactome) Activated DAAM1 recruits RHOA to the DVL complex in a WNT-dependent manner. Activated DAAM1 is able to bind to RHOA in both the GDP and GTP bound form in vitro, but displays higher affinity for GTP-bound RHOA (Habas et al, 2001; Liu et al, 2007). Studies in Xenopus have identified a DVL-associated weak guanine exchange factor (WGEF) that promotes the exchange of GDP for GTP on RHOA and is required for WNT-PCP signaling (Tanegashima et al, 2008). Evidence suggests that a similar GEF activity is associated with the DVL-DAAM1-RHOA complex in human cells, but the protein has not been definitively identified (Habas et al, 2001; Liu et al, 2007). GTP-bound RHOA relieves the auto-inhibition of RHO-associated kinases, allowing them to dimerize and effect changes to cytoskeletal organization (reviewed in Amano et al, 2010; Lai et al, 2009). DAAM1 may also play a more direct role in regulating the cytoskeleton in response to WNT signaling, since FH domains have been shown to bind actin directly to nucleate linear actin cables (Sagot et al, 2002; Watanabe and Higashida, 2004).
R-HSA-3965441 (Reactome) Studies with FZD receptors in zebrafish, Xenopus and mouse teratocarcinoma cells suggest that G-proteins are involved in signal transduction downstream of WNT5A/WNT11 signaling. Disrupting the function of G-protein alpha 0 and t2 subunits abrogates FZD-dependent calcium release and activation of potential downstream targets such as PKC, CaMK2 and calcineurin (Slusarski et al, 1997; Liu et al, 1999; Penzo-Mendez et al 2002; reviewed in Malbon et al, 2001; Angers and Moon, 2009)
R-HSA-3965444 (Reactome) After binding the FZD receptor, the G-protein alpha subunit exchanges GDP for GTP (reviewed in Malbon, 2004).
R-HSA-3965446 (Reactome) Binding of a number of 'non-canonical' WNT ligands, notably WNT5a and WNT11, to select FZD receptors has been shown to activate PLC and stimulate release of intracellular calcium stores (reviewed in De, 2011; Kuhl et al, 2000b). This WNT/Ca2+ pathway, which was first demonstrated in zebrafish and has subsequently been identified in Xenopus and human cells as well, activates CaMKII, PKC and calcineurin signaling (Slusarski et al, 1997a, b; Kuhl et al, 2000a, b; reviewed in Angers and Moon, 2009; Niehrs, 2012).
R-HSA-3965447 (Reactome) After nucleotide exchange, the G-protein alpha subunit dissociates from the beta-gamma complex (reviewed in Malbon, 2004). The G-alpha t2 and o subunits activate signaling through PDEs and promote the release of intracellular calcium (Ahumada et al, 2002; reviewed in Wang and Malbon, 2004) while the beta-gamma complex recruits PLC and initiates phosphoinositol signaling (reviewed in Smrcka, 2008), although both components may also play other roles.
R-HSA-3965450 (Reactome) The FH1 domain of DAAM1 recruits Profilin1 (PFN1) to the DVL:DAAM1 complex, and DAAM1 and PFN1 colocalize at stress fibers in response to WNT signaling (Sato et al, 2006). In addition to binding to FH domains, Profilin proteins bind to monomeric actin and in this way serve as a source of actin for polymerization of unbranched actin chains (Birbach, 2008; Goode and Eck, 2007). Depletion of PFN1 inhibits stress fiber formation in response to WNT signaling but does not affect DAAM1-mediated RHO A activation. In vivo, PFN1 is required downstream of DAAM1 for blastopore closure in Xenopus (Sato et al, 2006). In another study, PFN2 was also identified as an FH1 domain-interacting partner of DAAM1. The roles of PFN1 and PFN2 appear to be non-overlapping, however, as PFN2 is not required for blastopore closure in Xenopus but instead contributes to convergent extension (Khadka et al, 2009).
R-HSA-398040 (Reactome) G beta:gamma engages the PH domain of Phospholipase C beta, stimulating phospholipase activity, resulting in increased PIP2 hydrolysis.
R-HSA-398193 (Reactome) Phospholipase C (PLC) isozymes are a group of related proteins that cleave the polar head group from inositol phospholipids, typically in response to signals from cell surface receptors. They hydrolyze the highly phosphorylated lipid phosphatidylinositol 4,5-bisphosphate (PIP2) generating two products: inositol 1,4,5-trisphosphate (IP3), a universal calcium-mobilizing second messenger, and diacylglycerol (DAG), an activator of protein kinase C. PLC-beta isoforms are regulated by heterotrimeric GTP-binding proteins. PLC-beta 1 and 3 are widely expressed, with the highest concentrations found in (differing) specific regions of the brain. PLC-beta 2 is expressed at highest levels in cells of hematopoeitic origin; it is involved in leukocyte signaling and host defense. PLC-beta 4 is highly concentrated in cerebellar Purkinje and granule cells, the median geniculate body, whose axons terminate in the auditory cortex, and the lateral geniculate nucleus, where most retinal axons terminate in a visuotopic representation of each half of the visual field.
R-HSA-4086392 (Reactome) WNT signaling through WNT5A and FZD2 leads to a decrease in intracellular cGMP levels in a manner that is dependent on G alpha t2 and PDE6 (Ahumada et al, 2002; Ma and Wang, 2006; Ma and Wang, 2007, Bazhin et al, 2010). In response to decreasing cGMP levels, the activity of cGMP-dependent protein kinase G (PKG) also decreases, and this reduction in PKG activity is required both for intracellular calcium release and for activation of NFAT-dependent transcription in response to WNT5A (Ma and Wang, 2006).
R-HSA-4086393 (Reactome) Signaling by WNT5A and FZD2 activates PDE6 through G protein alpha subunit t2 (Liu et al, 1999; Ahumada et al, 2002). The discovery that G alpha t2 is involved in WNT:Ca2+ signaling was surprising, as this G protein subunit is best characterized for its role in visual transduction and its expression in vertebrates is almost exclusively restricted to the visual pathway (reviewed in Wang et al, 2004). Recent work in the WNT field has shown that a pathway similar to the visual transduction cascade exists in the mouse F9 teratocarcinoma cell line, CHO cells, zebrafish embryos as well as in a number of human cancer cell lines (Liu et al, 1999; Ahumada et al, 2002; Bazhin et al, 2010). PDE6 is a tetramer of two catalytic subunits, alpha and beta, held in an inactive conformation by two regulatory gamma subunits. Recruitment and binding with G alpha t2 relaxes the inhibitory effect of PDE6gamma and allows activation of the catalytic subunits (reviewed in Wensel, 2008). Activation of PDE6 in the WNT pathway may also depend on p38 MAPK (Ma and Wang, 2007).
R-HSA-4332356 (Reactome) Several studies in C. elegans and vertebrates suggest that a TAK1-NLK kinase cascade regulates the activity of the canonical WNT signaling pathway (Ishitani et al, 1999; Meneghini et al, 1999; Shin et al, 1999; Rocheleau et al, 1999). Activation of this MAPK cascade depends on CAMK2 activity downstream of WNT5a non-canonical signaling (Ishitani et al, 2003a, b). CAMK2 co-precipitates with TAK1/MAP3K7 upon co-transfection in HEK293 cells and calcium signaling activates MAP3K7 in a CAMK2-dependent manner (Ishitani et al, 2003a).
R-HSA-4332358 (Reactome) Dissociation of Ca2+/CaM from activated CAMK2 allows subsequent phosphorylations at Thr 305 and Thr 306. These phosphorylations, which occur within the CaM binding site, prevent reassociation of Ca2+/CaM (reviewed in Stratton et al, 2013).
R-HSA-4332359 (Reactome) Calcium release in response to WNT5A has been shown to activate calcium/calmodulin-dependent protein kinase 2 (CAMK2) (Kuhl et al, 2000; Ishitani et al, 2003a). Human cells have 4 genes encoding CAMK: alpha, beta, delta and gamma. Alpha and beta isoforms are expressed in neuronal tissue while delta and gamma isoforms have broad tissue distribution. The enzyme exists as either a homo- or hetero- dodecamer of ill-defined stoichiometry. In the inactive state, the autoinhibitory loop of CAMK2 blocks the active site. Upon binding of Ca2+/calmodulin, the autoinhibitory loop is displaced, allowing subsequent autophosphorylation at T286 in CAMK2 alpha and activation of the kinase (reviewed in Stratton et al, 2013).
R-HSA-4332363 (Reactome) Binding of CaM to CAMK2 displaces the autoinhibitory loop from the active site and allows CAMK2 to autophosphorylate T286, resulting in CAMK2 activation (reveiwed in Stratton et al, 2013).
R-HSA-4332388 (Reactome) Endogenous MAP3K7 is phosphorylated in a CAMK2-dependent fashion upon co-expression of WNT5A or after stimulation of calcium signaling (Ishitani et al, 2003a). Despite evidence that co-precipitated MAP3K7 is phosphorylated in vitro in the presence of CAMK2, direct phosphorylation of MAP3K7 by CAMK2 using purified proteins has not been demonstrated (Ishitani et al, 2003a). The roles of polyubiquitination and accessory proteins TAB1, 2 or 3 in MAP3K7 activation have not been investigated in the context of non-canonical WNT signaling and are therefore omitted from this reaction (reviewed in Dai et al, 2012).
R-HSA-4332390 (Reactome) Ectopic expression of Xwnt5a or Rfz2 in Xenopus embryos results in PKC translocation to the plasma membrane in a G-protein-dependent manner (Sheldahl et al, 1999; reviewed in Kuhl et al, 2000). PKC activation in response to WNT5A has also been demonstrated in human metastatic melanoma cell lines, contributing to cytoskeletal reorganization leading to invasiveness and motility as well as promoting the epithelial to mesenchymal transition (Weeraratna et al, 2002; Dissanyake et al, 2007; O'Connell et al, 2009)
R-HSA-4411365 (Reactome) The presence of a TCF/LEF:beta catenin complex at the promoter is an preliminary requirement for the activation of transcription at many WNT target genes (reviewed in Saito-Diaz et al, 2013). The ability of the TCF/LEF:beta-catenin complex to bind DNA is negatively regulated by NLK-dependent phosphorylation (Ishitani et al, 2003b). WNT targets AXIN2, DKK1, c-MYC and CCND1 all show decreased expression in A549 cells treated with shRNAs against NLK (Lv et al, 2013).
R-HSA-4411373 (Reactome) Dimerization and autophosphorylation at T298 is required for NLK nuclear localization (Ishitani et al, 2011).
R-HSA-4411383 (Reactome) Activated NLK phosphorylates TCF7L2 and LEF1 at serine and threonine residues that lie in the central region between the DNA-binding and beta-catenin interaction domains. Phosphorylation does not affect the ability of TCF/LEF to bind to beta-catenin, but the phosphorylated complex is not able to bind to target DNA or activate transcription as assessed by EMSA and reporter gene assays (Ishitani et al, 2003b).
R-HSA-4411402 (Reactome) NLK is activated in response to WNT5A in a CAMK2- and MAP3K7- dependent manner (Ishitani et al, 1999; Ishitani et al, 2003a,b). Homodimerization is required for NLK autophosphorylation at T298 and subsequent nuclear localization; mutation of C437 abolishes dimerization, kinase activity and nuclear translocation (Ishitani et al, 2011).
R-HSA-4420052 (Reactome) IP3 promotes the release of intracellular calcium after initiation of WNT signaling. As a downstream consequence of WNT ligand binding, cytosolic cGMP levels decrease, reducing the activity of PKG and relieving its repression of the IP3 receptor. Subsequent binding of IP3 to the receptor allows efflux of the intracellular calcium from the endoplasmic reticulum (Ahumada et al, 2002; Ma and Yang, 2006; reviewed in Hoffman, 2005).
R-HSA-4518575 (Reactome) NLK mRNA is a direct target of miR-92b which binds the 3' UTR and promotes degradation (Wang et al, 2013).
R-HSA-4518585 (Reactome) Translation of NLK mRNA is controlled by miR-92b. miR-92b binds the 3' UTR of NLK mRNA and promotes its degradation, resulting in decreased NLK protein levels. In this way, miR-92b positively regulates canonical TCF/LEF- and beta-catenin-dependent WNT signaling (Wang et al, 2013).
R-HSA-4551451 (Reactome) WNT/Ca2+ signaling has been shown to activate nuclear factor of activated T-cells (NFAT) in Xenopus, mouse F9 teratocarcinoma and human mammary epithelial cells (Saneyoshi et al, 2002; Ma and Wang, 2006; Demjek et al, 2006). NFAT is a transcription factor which induces genes with roles in development, cytokine production, cell-cell interaction and cancer (reviewed in Mancini and Toker, 2009). NFAT transcription activity is modulated by calcium and calcineurin concentration. In resting cells NFAT is cytoplasmic and hyperphosphorylated on fourteen conserved phosphoserine residues in three serine rich motifs termed SRR1, SP2 and SP. Upon Ca2+ induction, these serine residues are dephosphorylated by calcineurin, exposing a nuclear localization sequence and triggering translocation of the dephosphorylated NFAT-CaN complex to the nucleus. Among all the phosphorylation sites one of the sites in SRR-2 motif is not susceptible to dephosphorylation by CaN (Okamura et al, 2000; reviewed in Hogan et al, 2003).
R-HSA-4551453 (Reactome) Active PKG homodimers restrict Ca2+ release in the absence of stimulation by phosphorylating a component of the IP3 receptor complex. PKG homodimers are activated at high (sub- to micromolar) concentrations of cGMP. Upon binding of cGMP to the high and low affinity sites in the regulatory domain, an allosteric change in secondary structure makes the catalytic site accessible to substrate (reviewed in Hoffman, 2005). WNT5A signaling through FZD2 in mouse F9 teratocarcinoma cells results in a PDE6-dependent decrease in cGMP levels. Under low cGMP conditions, the N-terminal domain of PKG occludes the catalytic site, reducing PKG activity and promoting Ca2+ release through the IP3 receptor (Ahumada et al, 2002; Ma and Yang, 2006).
R-HSA-4551465 (Reactome) Dephosphorylated NFAT-calcineurin (CaN) complex translocates to nucleus, where it activates transcription (Okamura et al, 2000; Demjek et al, 2006; Saneyoshi et al, 2002; reviewed in Hogan et al, 2003).
R-HSA-4551555 (Reactome) RYK is an atypical receptor tyrosine kinase-like receptor that is required for craniofacial and skeletal development, axon guidance and neuronal differentiation. RYK has an extracellular WNT-binding WIF domain, a putative tetrabasic cleavage site, an intracellular PDZ domain and a cytosolic RTK-like catalytic site that is rendered inactive by a number of substitutions at conserved positions (reviewed in Fradkin et al, 2010; Keeble et al, 2006a). The WIF domain of RYK has been shown to interact with WNT1, 3, 3A and 5A (Keeble et al, 2006b; Liu et al, 2005; Macheda et al, 2012; Schmitt et al, 2006). RYK-deficient mice show disruptions to cochlear hair cell orientation suggesting a role for RYK in the planar cell polarity (PCP) pathway. Consistent with this, RYK binds to the PCP protein VANGL2 as assessed by co-immunoprecipitation from HEK293 cells. Formation of a RYK:VANGL2 complex appears to stabilize VANGL2 protein levels through an unknown mechanism (Macheda et al, 2012; Andre et al, 2012). RYK:VANGL may activate RHO A in response to WNT signaling (Macheda et al, 2012).
R-HSA-4551570 (Reactome) Based on studies in mouse, human VANGL2 is predicted to be phosphorylated and activated in response to WNT5A, possibly by CK1delta. Phosphorylation occurs on serine and threonine residues in 2 clusters and appears to be primed by phosphorylation at S5, S82 and S84. VANGL2 phosphorylation and activation occurs in a graded fashion in response to WNT5A distribution, helping to establish PCP asymmetry (Gao et al, 2011).
R-HSA-4551571 (Reactome) WNT5A binds ROR2 and VANGL2 to promote PCP in mouse limb buds. A complex of WNT5A:ROR2:VANGL2 is established along the WNT5A gradient in chondrocytes and regulates VANGL2 phosphorylation. This initiates the establishment of PCP asymmetry in these cells, a hallmark of the PCP pathway (Gao et al, 2011). ROR2 has been shown to function as a receptor or co-receptor for WNT5A in other mammalian systems (Oishi et al, 2003; Mikels and Nusse, 2006; reviewed in Minami et al, 2010), and WNT5A:ROR2 signaling can also negatively regulate canonical beta-catenin-dependent transcription as assessed by reporter gene activity (Mikels and Nusse, 2006; Li et al, 2008).
R-HSA-4608825 (Reactome) DVL2 is phosphorylated upon WNT5A stimulation of HEK293 cells. In human mammary carcinoma cells, DVL2 has been shown to be constititutively bound to PARD6A, irrespective of WNT stimulation and DVL phosphorylation (Narimatsu et al, 2009). PARD6A is a partitioning protein with known roles in the establishment of apico-basal polarity (reviewed in Chen and Zhang, 2013). More recently, PARD6A and the SMURF ubiquitin ligases have been implicated in the PCP pathway, targeting the core PCP protein Prickle1 for degradation (Narimatsu et al, 2009). WNT5A-dependent phosphorylation of DVL2 is required for the subsequent recruitment of SMURF1/2 ubiquitin ligases to the DVL2-PARD6A complex (Narimatsu et al, 2009)
R-HSA-4608852 (Reactome) PRICKLE1 is a conserved PCP protein with a localization pattern opposite to that of DVL. PRICKLE1 is recruited to the PARD6A:ppDVL2:SMURF complex through its interaction with DVL and is subsequently ubiquitinated by the E3 ligase activity of SMURF (Narimatsu et al, 2009; Jenny et al, 2005). This leads to localized degradation of PRICKLE1, contributing to its asymmetrical localization (Narimatsu et al, 2009). Note that in this reaction the interaction between PRICKLE1 and DVL is not shown.
R-HSA-4608854 (Reactome) The E3 ubiquitin ligases SMURF1/2 are recruited to the DVL:PARD6A complex after WNT5A stimulation. Recruitment depends on DVL2 phosphorylation and is mediated by the DEP domain of DVL2 that is important for PCP signaling (Narimatsu et al, 2009; Boutros et al, 1998). Smurf1 and 2 mutant mice show defects in convergent extension and neural tube closure, as well as misorientation of sensory hairs in the inner ear, phenotypes consistent with a role for SMURFs in the PCP pathway (Narimatsu et al, 2009).
R-HSA-4608855 (Reactome) Localized degradation of ub-PRICKLE1 contributes to asymmetric localization of the protein (Narimatsu et al, 2009).
R-HSA-4608862 (Reactome) VANGL2 is a core PCP protein. In Drosophila, asymmetric localization of Stbm (the fly VANGL homologue) and Fz to opposite membranes is a hallmark of the establishment of planar cell polarity (reviewed in Maung and Jenny, 2011). In the mouse inner-ear sensory hair cells, VANGL2 is also asymmetrically distributed in the membrane (Montcouquiol et al, 2003, 2006), and this distribution depends on a direct interaction with SCRIB, a peripheral membrane protein with no known role in fly PCP (reviewed in May-Simera and Kelley, 2012). Asymmetric VANGL2 localization in the mouse inner ear also depends on CELSR1, homologue to the Drosophila core PCP protein Flamingo, however a direct interaction between VANGL2 and CELSR1 has not been demonstrated (Montcouquiol et al, 2006).
R-HSA-4608866 (Reactome) FZD3 shows an asymmetric distribution in the membrane of the mouse inner-ear sensory hair cells in a manner that depends on a direct interaction with VANGL2 (Montcouquiol et al, 2006). In this respect, the vertebrate PCP pathway differs from that of flies, where Vangl2 and Fz are localized to opposing membranes within a single cell (reviewed in Maung and Jenny, 2011). Note that although this reaction depicts a complex of VANGL2:FZD3 with SCRIB, the existence of this ternary complex has not been demonstrated.
R-HSA-5099886 (Reactome) Binding of WNT5A to FZD receptors triggers the phosphorylation of DVL2 in the constitutive DVL2:PARD6A complex and is required for the SMURF-mediated degradation of the core PCP protein PRICKLE1 (Narimatsu et al, 2009)
R-HSA-5099899 (Reactome) WNT5A stimulation of FZD4-expressing HEK293 cells promotes internalization of the receptor, suggesting a receptor-ligand interaction (Chen et al, 2003).
R-HSA-5138432 (Reactome) WNT5A-dependent phosphorylation of DVL2 by PKC is required for the internalization of FZD4 (Chen et al, 2003; Yu et al, 2007). Endogenous PKC alpha beta and gamma co-immunoprecipitate with myc-DVL2, and phosphorylation increases the association with beta-arrestin 2 (ARRB2) (Chen et al, 2003).
R-HSA-5138433 (Reactome) Evidence suggests that FZD4 is endocytosed in a clathrin- and AP-2-dependent manner upon stimulation with WNT5A. Direct interactions have been demonstrated between DVL2 and the AP-2 component mu 2 mediated by simultaneous interaction with the DEP domain and a tetrapeptide motif YHEL of DVL2. Mutation of these regions abrogates FZD4 internalization and PCP signaling (Yu et al, 2007; Yu et al, 2010). DVL2 also interacts with beta-arrestin2 (ARBB2) in a PKC-dependent manner, and in vitro phosphorylation of DVL2 by PKC enhances the interaction between DVL2 and ARBB2 as assessed by co-immunoprecipitation (Chen et al, 2003). There is conflicting evidence on the requirement for ARBB2 for the internalization of FZD4 upon WNT5A signaling, however (Chen et al, 2003; Yu et al, 2007).
R-HSA-5138441 (Reactome) DVL2 is recruited to the WNT5A:FZD4 receptor complex as assessed by co-localization and co-immunoprecipitation (Chen et al, 2003).
R-HSA-5138459 (Reactome) WNT5A-dependent FZD4 uptake into clathrin-coated vesicles depends upon AP-2 and possibly ARBB2 (Chen et al, 2003; Yu et al, 2007). Evidence suggests that ARBB2 dissociates from the receptor-ligand complex before internalization (Chen et al, 2003).
R-HSA-5140741 (Reactome) WNT5A induces the internalization of FZD2, FZD5 and ROR2 in a clathrin-mediated route, but the activation of PKC is not required (Kurayoshi et al, 2007; Sato et al, 2010; Hanaki et al, 2012).
R-HSA-5140747 (Reactome) Stimulation of HEK293, HeLaS3 or KKLS gastric cancer cells with WNT5A promotes the internalization of FZD2, FZD5 and ROR2. Internalization is required for RAC activation downstream of WNT5A and subsequent activation of laminin gamma 2 gene expression which is associated with metastasis and invasion in gastric cancer (Sato et al, 2010; Hanaki et al, 2012; Yamamoto et al, 2009). Knockdown or inhibition of clathrin abrogates receptor internalization and RAC activation suggesting that clathrin-mediated endocytosis is required for this WNT5A-dependent signaling (Sato et al, 2010; Hanaki et al, 2012).
RAC:GTPR-HSA-3858475 (Reactome)
RHOA:GTP:Mg2+R-HSA-3858495 (Reactome)
ROR2R-HSA-4551571 (Reactome)
RYKR-HSA-4551555 (Reactome)
SCRIBR-HSA-4608862 (Reactome)
SMURFR-HSA-4608854 (Reactome)
TCF/LEF:CTNNB1R-HSA-4411383 (Reactome)
UbiquitinR-HSA-4608852 (Reactome)
VANGL2:SCRIB:FZD3ArrowR-HSA-4608866 (Reactome)
VANGL2:SCRIBArrowR-HSA-4608862 (Reactome)
VANGL2:SCRIBR-HSA-4608866 (Reactome)
VANGL2R-HSA-4551555 (Reactome)
VANGL2R-HSA-4551571 (Reactome)
VANGL2R-HSA-4608862 (Reactome)
WNT/Ca2+ FZDsR-HSA-3965446 (Reactome)
WNT5A-binding FZDsR-HSA-5099886 (Reactome)
WNT5A/11:FZD:G-protein (alpha o/t2) activeArrowR-HSA-3965444 (Reactome)
WNT5A/11:FZD:G-protein (alpha o/t2) activeR-HSA-3965447 (Reactome)
WNT5A/11:FZD:G-protein (alpha o/t2) inactiveArrowR-HSA-3965441 (Reactome)
WNT5A/11:FZD:G-protein (alpha o/t2) inactiveR-HSA-3965444 (Reactome)
WNT5A/11:FZD:G-protein (alpha o/t2) inactivemim-catalysisR-HSA-3965444 (Reactome)
WNT5A/11:FZDArrowR-HSA-3965446 (Reactome)
WNT5A/11:FZDArrowR-HSA-3965447 (Reactome)
WNT5A/11:FZDR-HSA-3965441 (Reactome)
WNT5A/WNT11R-HSA-3965446 (Reactome)
WNT5A:FZD4:DVL2ArrowR-HSA-5138441 (Reactome)
WNT5A:FZD4:DVL2R-HSA-5138432 (Reactome)
WNT5A:FZD4:p-DVL2:AP-2:clathrinArrowR-HSA-5138459 (Reactome)
WNT5A:FZD4:p-DVL2:ARRB2:AP-2:clathrinArrowR-HSA-5138433 (Reactome)
WNT5A:FZD4:p-DVL2:ARRB2:AP-2:clathrinR-HSA-5138459 (Reactome)
WNT5A:FZD4:p-DVL2ArrowR-HSA-5138432 (Reactome)
WNT5A:FZD4:p-DVL2R-HSA-5138433 (Reactome)
WNT5A:FZDArrowR-HSA-4608825 (Reactome)
WNT5A:FZDArrowR-HSA-5099886 (Reactome)
WNT5A:FZDs/RORArrowR-HSA-5140741 (Reactome)
WNT5A:FZDs/RORArrowR-HSA-5140747 (Reactome)
WNT5A:FZDs/RORR-HSA-5140747 (Reactome)
WNT:FZD:pDVLArrowR-HSA-3858482 (Reactome)
WNT:FZD:pDVLR-HSA-3858480 (Reactome)
WNT:FZDArrowR-HSA-3858480 (Reactome)
WNT:FZDArrowR-HSA-3858491 (Reactome)
WNT:FZDR-HSA-3858482 (Reactome)
activated PKC alphaArrowR-HSA-4332390 (Reactome)
cGMPR-HSA-4086392 (Reactome)
cGMPR-HSA-4551453 (Reactome)
clathrin:AP-2ArrowR-HSA-5140747 (Reactome)
clathrin:AP-2R-HSA-5138433 (Reactome)
miR-92b RISCR-HSA-4518575 (Reactome)
p-12S-NFATC1R-HSA-4551451 (Reactome)
p-DVLR-HSA-3858482 (Reactome)
p-T187-MAP3K7ArrowR-HSA-4332388 (Reactome)
p-T187-MAP3K7ArrowR-HSA-4411402 (Reactome)
p-T286 CAMK2:CaMArrowR-HSA-4332363 (Reactome)
p-T286 CAMK2:CaMR-HSA-4332358 (Reactome)
p-T286 CAMK2:CaMmim-catalysisR-HSA-4332358 (Reactome)
p-T286,305,306-CAMK2:MAP3K7ArrowR-HSA-4332356 (Reactome)
p-T286,305,306-CAMK2:MAP3K7R-HSA-4332388 (Reactome)
p-T286,T305,T306-CAMK2AArrowR-HSA-4332358 (Reactome)
p-T286,T305,T306-CAMK2AArrowR-HSA-4332388 (Reactome)
p-T286,T305,T306-CAMK2AR-HSA-4332356 (Reactome)
p-TCF/LEF:CTNNB1ArrowR-HSA-4411383 (Reactome)
pT298-NLK dimerArrowR-HSA-4411373 (Reactome)
pT298-NLK dimerArrowR-HSA-4411402 (Reactome)
pT298-NLK dimerR-HSA-4411373 (Reactome)
pT298-NLK dimerTBarR-HSA-4411365 (Reactome)
pT298-NLK dimermim-catalysisR-HSA-4411383 (Reactome)
pT497,T638,S657-PRKCAR-HSA-4332390 (Reactome)
pp-DVLArrowR-HSA-3858480 (Reactome)
pp-DVLR-HSA-3858475 (Reactome)
pp-DVLR-HSA-3858489 (Reactome)
ppDVL:DAAM1:PFN1ArrowR-HSA-3965450 (Reactome)
ppDVL:DAAM1:RHOA:GTPArrowR-HSA-3858495 (Reactome)
ppDVL:DAAM1ArrowR-HSA-3858489 (Reactome)
ppDVL:DAAM1R-HSA-3858495 (Reactome)
ppDVL:DAAM1R-HSA-3965450 (Reactome)
ppDVL:RAC:GTPArrowR-HSA-3858475 (Reactome)
ub-PRICKLE1ArrowR-HSA-4608852 (Reactome)
ub-PRICKLE1R-HSA-4608855 (Reactome)
unknown kinasemim-catalysisR-HSA-3858480 (Reactome)
unknown kinasemim-catalysisR-HSA-4332388 (Reactome)
unknown kinasemim-catalysisR-HSA-4551570 (Reactome)
unknown kinasemim-catalysisR-HSA-4608825 (Reactome)
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP3558"
Personal tools